Breaking News Instant updates and real-time market news.

COP

ConocoPhillips

$45.85 /

-2.45 (-5.07%)

06:18
06/11/20
06/11
06:18
06/11/20
06:18

ConocoPhillips CEO surprised by quick rebound in oil prices, Reuters reports

ConocoPhillips CEO Ryan Lance said Wednesday that he was surprised at the quick recovery in U.S. oil prices that dropped into the negative territory in April and said he expects prices to remain volatile in the near term, Reuters' Taru Jain reports. "We were surprised it came back this strong this quickly," Lance said on a webinar hosted by the Independent Petroleum Association of America. Lance added that a continued rise in crude storage could drag down the prices as more producers reverse some production cuts announced in over the last couple of months. Reference Link

  • 30

    Jul

COP ConocoPhillips
$45.85 /

-2.45 (-5.07%)

05/21/20 Mizuho
ConocoPhillips price target raised to $37 from $33 at Mizuho
05/04/20 Goldman Sachs
ConocoPhillips upgraded to Conviction Buy from Buy at Goldman Sachs
05/01/20 Susquehanna
ConocoPhillips price target raised to $50 from $40 at Susquehanna
05/01/20 BofA
ConocoPhillips downgraded to Neutral on valuation at BofA

TODAY'S FREE FLY STORIES

Hot Stocks
ANI Pharmaceuticals acquires Fluconazole Tablets for $3M » 08:31
07/06/20
07/06
08:31
07/06/20
08:31
ANIP

ANI Pharmaceuticals

$30.90 /

-1.175 (-3.66%)

ANI Pharmaceuticals said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANIP ANI Pharmaceuticals
$30.90 /

-1.175 (-3.66%)

ANIP ANI Pharmaceuticals
$30.90 /

-1.175 (-3.66%)

05/08/20 Raymond James
ANI Pharmaceuticals price target lowered to $49 from $65 at Raymond James
05/07/20 Cantor Fitzgerald
Cantor downgrades ANI Pharmaceuticals to Neutral on near-term uncertainty
05/07/20 Cantor Fitzgerald
ANI Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
09/11/19 Guggenheim
ANI Pharmaceuticals initiated with a Buy at Guggenheim
ANIP ANI Pharmaceuticals
$30.90 /

-1.175 (-3.66%)

Options
Three new option listings and four option delistings on July 6th » 08:30
07/06/20
07/06
08:30
07/06/20
08:30
SNEX

StoneX Group

$55.83 /

+0.84 (+1.53%)

, CVTI

Covenant Transportation

/

+

, INTL

INTL FCStone

$0.00 /

+ (+0.00%)

, PTLA

Portola Pharmaceuticals

$18.01 /

+ (+0.00%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNEX StoneX Group
$55.83 /

+0.84 (+1.53%)

CVTI Covenant Transportation
/

+

INTL INTL FCStone
$0.00 /

+ (+0.00%)

PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

SNEX StoneX Group
$55.83 /

+0.84 (+1.53%)

CVTI Covenant Transportation
/

+

05/28/20 Wolfe Research
Covenant Transportation upgraded to Outperform from Peer Perform at Wolfe Research
05/22/20
Fly Intel: Top five analyst upgrades
05/22/20 Stephens
Stephens upgrades 'too cheap' Covenant Transportation amid structural changes
05/22/20 Stephens
Covenant Transportation upgraded to Overweight from Equal Weight at Stephens
INTL INTL FCStone
$0.00 /

+ (+0.00%)

06/09/20 B. Riley FBR
Gain Capital downgraded to Neutral from Buy at B. Riley FBR
02/28/20 JPMorgan
Gain Capital downgraded to Neutral from Overweight at JPMorgan
PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

05/07/20 Stifel
Portola deal highlights value of PhaseBio's PB2452, says Stifel
05/06/20 B. Riley FBR
B. Riley boosts CytoSorbents target, says Portola deal highlights value
05/05/20 Citi
Portola Pharmaceuticals downgraded to Neutral from Buy at Citi
05/05/20 Jefferies
Jefferies sees Portola acquisition as neutral for Alexion
CVTI Covenant Transportation
/

+

PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

  • 14
    Aug
PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

PTLA Portola Pharmaceuticals
$18.01 /

+ (+0.00%)

Hot Stocks
Ezcorp CEO Stuart Grimshaw to step down, Jason Kulas to succeed » 08:29
07/06/20
07/06
08:29
07/06/20
08:29
EZPW

Ezcorp

$5.91 /

-0.05 (-0.84%)

, SC

Santander Consumer

$17.91 /

+0.175 (+0.99%)

Ezcorp (EZPW) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EZPW Ezcorp
$5.91 /

-0.05 (-0.84%)

SC Santander Consumer
$17.91 /

+0.175 (+0.99%)

EZPW Ezcorp
$5.91 /

-0.05 (-0.84%)

12/03/19 B. Riley FBR
Ezcorp price target lowered to $12 from $14 at B. Riley FBR
10/08/19 Jefferies
Jefferies downgrades Ezcorp to Hold on misaligned corporate governance
SC Santander Consumer
$17.91 /

+0.175 (+0.99%)

06/03/20 Stephens
Stephens says Santander Consumer may benefit if Wells pulling back on auto loans
05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
03/17/20 Barclays
Santander Consumer downgraded to Underweight from Equal Weight at Barclays
01/06/20 Stephens
Stephens upgrades Santander Consumer to Equal Weight ahead of expected buybacks
EZPW Ezcorp
$5.91 /

-0.05 (-0.84%)

SC Santander Consumer
$17.91 /

+0.175 (+0.99%)

SC Santander Consumer
$17.91 /

+0.175 (+0.99%)

Upgrade
B. Riley FBR upgrades Marcus to Buy with 100% potential upside » 08:28
07/06/20
07/06
08:28
07/06/20
08:28
MCS

Marcus

$13.25 /

-0.26 (-1.92%)

B. Riley FBR analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCS Marcus
$13.25 /

-0.26 (-1.92%)

MCS Marcus
$13.25 /

-0.26 (-1.92%)

04:42 Today B. Riley FBR
Marcus upgraded to Buy from Neutral at B. Riley FBR
06/26/20 Benchmark
Marcus' recent weakness a buying opportunity, says Benchmark
04/17/20 B. Riley FBR
White House guidelines give some clarity to film exhibitors, says B. Riley FBR
04/15/20 Benchmark
Marcus upgraded to Buy on long-term optimism at Benchmark
MCS Marcus
$13.25 /

-0.26 (-1.92%)

MCS Marcus
$13.25 /

-0.26 (-1.92%)

Downgrade
Staar Surgical downgraded to Neutral from Buy at Sidoti » 08:28
07/06/20
07/06
08:28
07/06/20
08:28
STAA

Staar Surgical

$61.70 /

+1.29 (+2.14%)

Sidoti analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STAA Staar Surgical
$61.70 /

+1.29 (+2.14%)

STAA Staar Surgical
$61.70 /

+1.29 (+2.14%)

06/24/20 BTIG
Staar Surgical downgraded to Neutral from Buy at BTIG
06/15/20 Jefferies
Staar Surgical initiated with a Buy at Jefferies
03/04/20
BTIG healthcare analysts to hold an analyst/industry conference call
01/31/20 Benchmark
Too early to call China emergency impact on Staar Surgical, says Benchmark
STAA Staar Surgical
$61.70 /

+1.29 (+2.14%)

Hot Stocks
MyoKardia appoints Denelle Waynick as General Counsel and Corporate Secretary » 08:27
07/06/20
07/06
08:27
07/06/20
08:27
MYOK

MyoKardia

$94.12 /

+0.35 (+0.37%)

MyoKardia announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYOK MyoKardia
$94.12 /

+0.35 (+0.37%)

MYOK MyoKardia
$94.12 /

+0.35 (+0.37%)

05/20/20 Cantor Fitzgerald
MyoKardia price target raised to $188 from $95 at Cantor Fitzgerald
05/14/20 BMO Capital
MyoKardia price target raised to $148 from $90 at BMO Capital
05/12/20 Citi
MyoKardia takeout value in $160 to $190 per share range, says Citi
05/11/20 Cowen
MyoKardia price target raised to $145 from $104 at Cowen
MYOK MyoKardia
$94.12 /

+0.35 (+0.37%)

  • 13
    May
MYOK MyoKardia
$94.12 /

+0.35 (+0.37%)

Hot Stocks
Adial announces approval to commence landmark ONWARD trial in Sweden, Estonia » 08:26
07/06/20
07/06
08:26
07/06/20
08:26
ADIL

Adial Pharmaceuticals

$1.36 /

-0.05 (-3.55%)

Adial Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADIL Adial Pharmaceuticals
$1.36 /

-0.05 (-3.55%)

ADIL Adial Pharmaceuticals
$1.36 /

-0.05 (-3.55%)

Upgrade
Acasti Pharma upgraded to Buy with $2 target at B. Riley FBR » 08:25
07/06/20
07/06
08:25
07/06/20
08:25
ACST

Acasti Pharma

$0.53 /

+0.0158 (+3.05%)

B. Riley FBR analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACST Acasti Pharma
$0.53 /

+0.0158 (+3.05%)

ACST Acasti Pharma
$0.53 /

+0.0158 (+3.05%)

07:12 Today B. Riley FBR
Acasti Pharma upgraded to Buy from Neutral at B. Riley FBR
02/18/20 H.C. Wainwright
Acasti Pharma price target lowered to $3 from $6 at H.C. Wainwright
01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
ACST Acasti Pharma
$0.53 /

+0.0158 (+3.05%)

ACST Acasti Pharma
$0.53 /

+0.0158 (+3.05%)

Hot Stocks
Lithium Americas workers test positive for COVID-19 at Cauchari-Olaroz project » 08:24
07/06/20
07/06
08:24
07/06/20
08:24
LAC

Lithium Americas

$5.10 /

-0.12 (-2.30%)

Lithium Americas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAC Lithium Americas
$5.10 /

-0.12 (-2.30%)

LAC Lithium Americas
$5.10 /

-0.12 (-2.30%)

06/25/20 BMO Capital
Lithium Americas price target raised to C$5 from C$4.40 at BMO Capital
LAC Lithium Americas
$5.10 /

-0.12 (-2.30%)

Hot Stocks
SeaChange extends salary reduction plan » 08:23
07/06/20
07/06
08:23
07/06/20
08:23
SEAC

SeaChange

$1.45 /

+0.005 (+0.35%)

SeaChange announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEAC SeaChange
$1.45 /

+0.005 (+0.35%)

SEAC SeaChange
$1.45 /

+0.005 (+0.35%)

04/08/20
SeaChange participates in a conference call hosted by Lake Street
12/05/19 Lake Street
Lake Street upgrades SeaChange to Buy, boosts target to $4.50
12/05/19 Lake Street
SeaChange upgraded to Buy from Hold at Lake Street
SEAC SeaChange
$1.45 /

+0.005 (+0.35%)

SEAC SeaChange
$1.45 /

+0.005 (+0.35%)

Conference/Events
XPO Logistics management to meet virtually with Oppenheimer » 08:23
07/06/20
07/06
08:23
07/06/20
08:23
XPO

XPO Logistics

$76.50 /

-0.01 (-0.01%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

06:46 Today Barclays
XPO Logistics price target raised to $75 from $65 at Barclays
06/17/20 Deutsche Bank
XPO Logistics price target raised to $88 from $84 at Deutsche Bank
06/17/20 Deutsche Bank
XPO Logistics named short-term buy idea at Deutsche Bank
06/10/20 Morgan Stanley
Morgan Stanley starts 'undervalued' TFI International at Overweight
XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

XPO XPO Logistics
$76.50 /

-0.01 (-0.01%)

Recommendations
Avita Medical price target raised to $45 from $9 at Oppenheimer » 08:22
07/06/20
07/06
08:22
07/06/20
08:22
RCEL

Avita Medical

$29.90 /

+0.48 (+1.63%)

Oppenheimer analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCEL Avita Medical
$29.90 /

+0.48 (+1.63%)

RCEL Avita Medical
$29.90 /

+0.48 (+1.63%)

04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
03/05/20 Lake Street
Avita Medical pullback brings buying opportunity, says Lake Street
03/03/20 BTIG
Avita Medical initiated with a Buy at BTIG
12/31/19 Lake Street
Avita Medical's new CFO a 'perfect fit,' says Lake Street
RCEL Avita Medical
$29.90 /

+0.48 (+1.63%)

Upgrade
CyberArk upgraded to Buy from Neutral at Monness Crespi » 08:22
07/06/20
07/06
08:22
07/06/20
08:22
CYBR

CyberArk

$103.04 /

+0.16 (+0.16%)

Monness Crespi analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

08:15 Today Monness Crespi
CyberArk upgraded to Buy from Neutral at Monness Crespi
05/14/20 DA Davidson
CyberArk price target raised to $85 from $80 at DA Davidson
05/14/20 Guggenheim
CyberArk price target lowered to $115 from $134 at Guggenheim
05/14/20 UBS
CyberArk price target lowered to $94 from $104 at UBS
CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

Hot Stocks
ATIF Holdings establishes headquarters in Los Angeles » 08:21
07/06/20
07/06
08:21
07/06/20
08:21
ATIF

ATIF Holdings

$1.92 /

+0.02 (+1.05%)

ATIF Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATIF ATIF Holdings
$1.92 /

+0.02 (+1.05%)

Conference/Events
Ansys management to meet virtaully with Oppenheimer » 08:20
07/06/20
07/06
08:20
07/06/20
08:20
ANSS

Ansys

$298.05 /

+3.53 (+1.20%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANSS Ansys
$298.05 /

+3.53 (+1.20%)

ANSS Ansys
$298.05 /

+3.53 (+1.20%)

03/13/20 Wedbush
Ansys price target lowered to $249 from $295 at Wedbush
02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
ANSS Ansys
$298.05 /

+3.53 (+1.20%)

Recommendations
Carvana price target raised to $125 from $90 at Wedbush » 08:19
07/06/20
07/06
08:19
07/06/20
08:19
CVNA

Carvana

$128.61 /

+3.2 (+2.55%)

Wedbush analyst Seth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$128.61 /

+3.2 (+2.55%)

CVNA Carvana
$128.61 /

+3.2 (+2.55%)

07:59 Today Wedbush
Wedbush bullish on Vroom, initiates with an Outperform
06:07 Today JMP Securities
Carvana price target raised to $155 from $105 at JMP Securities
07/05/20 Goldman Sachs
Carvana initiated with a Neutral at Goldman Sachs
06/26/20 Wells Fargo
Carvana price target raised to $135 from $115 at Wells Fargo
CVNA Carvana
$128.61 /

+3.2 (+2.55%)

  • 19
    May
CVNA Carvana
$128.61 /

+3.2 (+2.55%)

CVNA Carvana
$128.61 /

+3.2 (+2.55%)

CVNA Carvana
$128.61 /

+3.2 (+2.55%)

Periodicals
Fiat Chrysler may cut special dividend related to PSA merger, Reuters reports » 08:19
07/06/20
07/06
08:19
07/06/20
08:19
FCAU

Fiat Chrysler

$9.96 /

+0.06 (+0.61%)

, PUGOY

Peugeot

$0.00 /

+ (+0.00%)

Fiat Chrysler (FCAU) may…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FCAU Fiat Chrysler
$9.96 /

+0.06 (+0.61%)

PUGOY Peugeot
$0.00 /

+ (+0.00%)

FCAU Fiat Chrysler
$9.96 /

+0.06 (+0.61%)

06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/22/20 Redburn
Fiat Chrysler upgraded to Buy from Neutral at Redburn
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
PUGOY Peugeot
$0.00 /

+ (+0.00%)

06/30/20 UBS
Peugeot upgraded to Buy from Neutral at UBS
06/22/20 Redburn
Peugeot upgraded to Buy from Neutral at Redburn
04/09/20 RBC Capital
Peugeot price target raised to EUR 13 from EUR 4 at RBC Capital
01/09/20 Exane BNP Paribas
Peugeot upgraded to Outperform from Neutral at Exane BNP Paribas
FCAU Fiat Chrysler
$9.96 /

+0.06 (+0.61%)

FCAU Fiat Chrysler
$9.96 /

+0.06 (+0.61%)

PUGOY Peugeot
$0.00 /

+ (+0.00%)

FCAU Fiat Chrysler
$9.96 /

+0.06 (+0.61%)

FCAU Fiat Chrysler
$9.96 /

+0.06 (+0.61%)

Hot Stocks
Lineage Cell Therapeutics receives extension of development grant for OpRegen » 08:18
07/06/20
07/06
08:18
07/06/20
08:18
LCTX

Lineage Cell Therapeutics

$0.79 /

-0.0364 (-4.42%)

Lineage Cell Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LCTX Lineage Cell Therapeutics
$0.79 /

-0.0364 (-4.42%)

LCTX Lineage Cell Therapeutics
$0.79 /

-0.0364 (-4.42%)

06/09/20 H.C. Wainwright
Lineage Cell Therapeutics price target raised to $7 from $4 at H.C. Wainwright
06/01/20 H.C. Wainwright
Lineage Cell evidence 'preliminary,' but 'unprecedented,' says H.C. Wainwright
05/06/20 H.C. Wainwright
Lineage update shows OpRegen 'nicely on track,' says H.C. Wainwright
LCTX Lineage Cell Therapeutics
$0.79 /

-0.0364 (-4.42%)

Hot Stocks
GTT Communications appoints Don MacNeil as COO » 08:17
07/06/20
07/06
08:17
07/06/20
08:17
GTT

GTT Communications

$8.21 /

+0.245 (+3.08%)

GTT Communications said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

05/26/20 Raymond James
GTT Communications upgraded to Outperform from Market Perform at Raymond James
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

Periodicals
Top Qiagen investor opposes Thermo Fisher takeover deal, Reuters reports » 08:17
07/06/20
07/06
08:17
07/06/20
08:17
QGEN

Qiagen

$42.50 /

-0.2 (-0.47%)

, TMO

Thermo Fisher

$365.94 /

+5.805 (+1.61%)

A top Qiagen (QGEN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QGEN Qiagen
$42.50 /

-0.2 (-0.47%)

TMO Thermo Fisher
$365.94 /

+5.805 (+1.61%)

QGEN Qiagen
$42.50 /

-0.2 (-0.47%)

03/04/20 Stifel
Qiagen deal a positive for Thermo Fisher, says Stifel
03/04/20 Berenberg
Qiagen downgraded to Hold from Buy at Berenberg
03/03/20 Piper Sandler
Danaher unlikely to make competing bid for Qiagen, says Piper Sandler
02/05/20 Piper Sandler
Qiagen price target raised to $36 from $29 at Piper Sandler
TMO Thermo Fisher
$365.94 /

+5.805 (+1.61%)

04/23/20 SVB Leerink
Thermo Fisher price target raised to $365 from $330 at SVB Leerink
04/23/20 Needham
Thermo Fisher price target raised to $383 from $341 at Needham
04/21/20 Wells Fargo
Danaher price target raised to $170 from $155 at Wells Fargo
03/30/20 Wells Fargo
Thermo Fisher price target lowered to $300 from $345 at Wells Fargo
QGEN Qiagen
$42.50 /

-0.2 (-0.47%)

TMO Thermo Fisher
$365.94 /

+5.805 (+1.61%)

QGEN Qiagen
$42.50 /

-0.2 (-0.47%)

TMO Thermo Fisher
$365.94 /

+5.805 (+1.61%)

QGEN Qiagen
$42.50 /

-0.2 (-0.47%)

TMO Thermo Fisher
$365.94 /

+5.805 (+1.61%)

QGEN Qiagen
$42.50 /

-0.2 (-0.47%)

TMO Thermo Fisher
$365.94 /

+5.805 (+1.61%)

Recommendations
Uber's acquisition of Postmates 'a smart strategic move,' says Wedbush » 08:16
07/06/20
07/06
08:16
07/06/20
08:16
UBER

Uber

$30.66 /

+0.24 (+0.79%)

, DASH

DoorDash

$0.00 /

+ (+0.00%)

, GRUB

GrubHub

$69.79 /

+0.73 (+1.06%)

Wedbush analyst Ygal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$30.66 /

+0.24 (+0.79%)

DASH DoorDash
$0.00 /

+ (+0.00%)

GRUB GrubHub
$69.79 /

+0.73 (+1.06%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

07/01/20 BTIG
Uber consensus likely aggressive, says BTIG
06/30/20 SunTrust
Uber shouldn't face regulatory issues if it buys Postmates, says Suntrust
06/25/20 Deutsche Bank
Yandex interest in Uber's minority stake modest positive, says Deutsche Bank
06/16/20 JPMorgan
JPMorgan continues to prefer Facebook, Snap in online advertising
DASH DoorDash
$0.00 /

+ (+0.00%)

GRUB GrubHub
$69.79 /

+0.73 (+1.06%)

07/01/20 Northcoast
Chipotle's GrubHub deal should drive SSS growth in 2H, says Northcoast
06/30/20 SunTrust
Uber shouldn't face regulatory issues if it buys Postmates, says Suntrust
06/25/20 Canaccord
Canaccord downgraded GrubHub after announced merger
06/25/20 Canaccord
GrubHub downgraded to Hold from Buy at Canaccord
UBER Uber
$30.66 /

+0.24 (+0.79%)

GRUB GrubHub
$69.79 /

+0.73 (+1.06%)

  • 11
    Feb
  • 07
    Nov
  • 06
    Nov
UBER Uber
$30.66 /

+0.24 (+0.79%)

GRUB GrubHub
$69.79 /

+0.73 (+1.06%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

DASH DoorDash
$0.00 /

+ (+0.00%)

GRUB GrubHub
$69.79 /

+0.73 (+1.06%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

GRUB GrubHub
$69.79 /

+0.73 (+1.06%)

Hot Stocks
GTT Communications appoints Ernie Ortega as Interim CEO » 08:16
07/06/20
07/06
08:16
07/06/20
08:16
GTT

GTT Communications

$8.21 /

+0.245 (+3.08%)

GTT Communications…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

05/26/20 Raymond James
GTT Communications upgraded to Outperform from Market Perform at Raymond James
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

GTT GTT Communications
$8.21 /

+0.245 (+3.08%)

Upgrade
CyberArk upgraded to Buy from Neutral at Monness Crespi » 08:15
07/06/20
07/06
08:15
07/06/20
08:15
CYBR

CyberArk

$103.04 /

+0.16 (+0.16%)

Monness Crespi analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

05/14/20 DA Davidson
CyberArk price target raised to $85 from $80 at DA Davidson
05/14/20 Guggenheim
CyberArk price target lowered to $115 from $134 at Guggenheim
05/14/20 UBS
CyberArk price target lowered to $94 from $104 at UBS
05/13/20 William Blair
William Blair keeps Outperform on CyberArk following 'solid' quarter
CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

CYBR CyberArk
$103.04 /

+0.16 (+0.16%)

Hot Stocks
Freeport McMoRan sees Q2 adjusted EBITDA $650M » 08:14
07/06/20
07/06
08:14
07/06/20
08:14
FCX

Freeport McMoRan

$11.49 /

+ (+0.00%)

Assuming an average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FCX Freeport McMoRan
$11.49 /

+ (+0.00%)

FCX Freeport McMoRan
$11.49 /

+ (+0.00%)

06/11/20 Deutsche Bank
Freeport McMoRan price target raised to $13.50 from $11 at Deutsche Bank
04/27/20 Scotiabank
Scotiabank upgrades Freeport on 'significantly improved' cash flow outlook
04/27/20
Fly Intel: Top five analyst upgrades
04/27/20 Eight Capital
Freeport McMoRan upgraded to Buy from Neutral at Eight Capital
FCX Freeport McMoRan
$11.49 /

+ (+0.00%)

FCX Freeport McMoRan
$11.49 /

+ (+0.00%)

FCX Freeport McMoRan
$11.49 /

+ (+0.00%)

FCX Freeport McMoRan
$11.49 /

+ (+0.00%)

Conference/Events
Alpine Immune Sciences management to meet virtually with Oppenheimer » 08:14
07/06/20
07/06
08:14
07/06/20
08:14
ALPN

Alpine Immune Sciences

$10.22 /

+0.76 (+8.03%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALPN Alpine Immune Sciences
$10.22 /

+0.76 (+8.03%)

ALPN Alpine Immune Sciences
$10.22 /

+0.76 (+8.03%)

06/19/20 Wedbush
Alpine Immune price target raised to $22 from $10 at Wedbush
06/18/20 Piper Sandler
Alpine Immune Sciences price target raised to $21 from $8 at Piper Sandler
06/04/20 Piper Sandler
Alpine data demonstrate application of platform technology, says Piper Sandler
04/27/20 Piper Sandler
Piper Sandler backs Overweight rating for Alpine after study design presented
ALPN Alpine Immune Sciences
$10.22 /

+0.76 (+8.03%)

ALPN Alpine Immune Sciences
$10.22 /

+0.76 (+8.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.